Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

On Tuesday (Jan 14), Wong took to social media to share two photos of his medical reports, revealing that he suffers from Stage 3B chronic kidney disease (CKD). According to the National Kidney ...

It showed that 1 mg Ozempic led to a 24 per cent reduced risk of worsening kidney disease and kidney failure (end-stage ...

TAIPEI – Hong Kong actor Wong He has been diagnosed with kidney failure. He took to social media on Jan 14 to share two photos of his medical reports, revealing that he suffers from Stage 3B ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

Novo Nordisk’s Ozempic (semaglutide) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of ...

The kidney failure rate was 10.5 vs 9.2 per 100 person-years, respectively. Subgroup analyses showed that patients with stage 3 CKD had a significant 39% increased risk of ESKD, but patients with ...

A growing body of evidence links use of proton pump inhibitors to kidney problems, including kidney failure in patients with existing CKD.